Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,277 publicly listed stocks with a combined market cap of $1.95 Trillion. PATTIES FOODS leads the sector with a market cap of $835.39 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$1.95 Trillion
Companies Listed
1,277
Largest Company
PATTIES FOODS
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 301 |
PATTIES FOODS
F:PH4 |
$835.39 Million | €714.56 Million | Germany | €0.45 | -3.31% | -11.99% | 0.00 |
| 302 |
Jiangsu Aidea Pharmaceutical Co Ltd
SHG:688488 |
$833.09 Million | CN¥5.69 Billion | China | CN¥13.53 | -8.15% | -14.48% | 329.15 Million |
| 303 |
Arbutus Biopharma Corp
NASDAQ:ABUS |
$831.63 Million | $831.63 Million | USA | $4.41 | +2.80% | +1.85% | 56.47 Million |
| 304 |
Theravance Biopharma Inc
F:0TB |
$828.57 Million | €708.72 Million | Germany | €14.50 | -1.36% | -1.36% | 0.00 |
| 305 |
Oric Pharmaceuticals Inc
NASDAQ:ORIC |
$828.14 Million | $828.14 Million | USA | $11.64 | +3.19% | +8.28% | 41.65 Million |
| 306 |
Xencor Inc
NASDAQ:XNCR |
$827.65 Million | $827.65 Million | USA | $21.49 | +10.04% | +10.15% | 26.61 Million |
| 307 |
Kura Oncology Inc
NASDAQ:KURA |
$826.49 Million | $826.49 Million | USA | $9.31 | +4.26% | -11.67% | 38.49 Million |
| 308 |
DBV Technologies S.A.
PA:DBV |
$825.45 Million | €706.05 Million | France | €2.39 | -0.58% | -2.77% | 23.19 Million |
| 309 |
Kalvista Pharmaceuticals Inc
NASDAQ:KALV |
$820.37 Million | $820.37 Million | USA | $27.00 | +0.00% | +0.19% | 70.92 Million |
| 310 |
DBV Technologies
NASDAQ:DBVT |
$817.32 Million | $817.32 Million | USA | $13.81 | +0.58% | +1.32% | 7.01 Million |
| 311 |
Youcare Pharmaceutical Group Co. Ltd. A
SHG:688658 |
$791.51 Million | CN¥5.41 Billion | China | CN¥12.02 | -2.51% | -5.50% | 425.77 Million |
| 312 |
Seegene Inc
KQ:096530 |
$785.95 Million | ₩1.16 Trillion | Korea | ₩25150.00 | -1.18% | -6.51% | 5.57 Million |
| 313 |
Hangzhou Biotest Biotech Co Ltd
SHG:688767 |
$781.87 Million | CN¥5.34 Billion | China | CN¥35.78 | +3.62% | +5.86% | 60.62 Million |
| 314 |
Adlai Nortye Ltd. American Depositary Shares
NASDAQ:ANL |
$763.55 Million | $763.55 Million | USA | $13.00 | +7.35% | -1.96% | 5.80 Million |
| 315 |
PHARMING GRP SP. ADRS
F:PHG |
$762.66 Million | €652.34 Million | Germany | €13.90 | -0.71% | -4.79% | 447.00 |
| 316 |
Pharming Group NV
NASDAQ:PHAR |
$759.22 Million | $759.22 Million | USA | $10.75 | -10.49% | -17.05% | 181.37K |
| 317 |
Supriya Lifescience Limited
NSE:SUPRIYA |
$748.45 Million | Rs69.21 Billion | India | Rs859.90 | +0.03% | +2.34% | 9.40 Million |
| 318 |
Faeth Therapeutics, Inc.
NASDAQ:FTH |
$742.94 Million | $742.94 Million | USA | $28.82 | -0.38% | +0.56% | 5.99 Million |
| 319 |
GH RESEARCH PLC DL-025
F:1KA |
$737.24 Million | €630.60 Million | Germany | €24.00 | +0.00% | -1.64% | 0.00 |
| 320 |
Astria Therapeutics Inc
NASDAQ:ATXS |
$718.13 Million | $718.13 Million | USA | $5873.65 | +10.87% | +47002.25% | 16.63 Million |
| 321 |
CytomX Therapeutics Inc
NASDAQ:CTMX |
$714.07 Million | $714.07 Million | USA | $3.28 | +3.47% | -1.50% | 111.18 Million |
| 322 |
Pharming Group NV
AS:PHARM |
$713.34 Million | €610.16 Million | Netherlands | €0.88 | -20.27% | -23.31% | 236.86 Million |
| 323 |
Omeros Corporation
NASDAQ:OMER |
$712.90 Million | $712.90 Million | USA | $11.93 | +2.23% | +21.24% | 45.95 Million |
| 324 |
XOMA Royalty Corporation
NASDAQ:XOMA |
$710.16 Million | $710.16 Million | USA | $40.17 | +0.00% | -8.39% | 8.18 Million |
| 325 |
PYC Therapeutics Ltd
AU:PYC |
$707.85 Million | AU$1.00 Billion | Australia | AU$1.68 | +3.08% | +4.36% | 27.75 Million |
| 326 |
Phathom Pharmaceuticals Inc
NASDAQ:PHAT |
$704.46 Million | $704.46 Million | USA | $9.03 | -22.42% | -22.82% | 33.15 Million |
| 327 |
Shouyao Holdings (Beijing) Co. Ltd. A
SHG:688197 |
$693.35 Million | CN¥4.74 Billion | China | CN¥31.86 | -6.02% | -15.33% | 100.31 Million |
| 328 |
SpyGlass Pharma, Inc.
NASDAQ:SGP |
$687.22 Million | $687.22 Million | USA | $22.72 | +3.70% | +10.61% | 4.16 Million |
| 329 |
Beijing Konruns Pharmaceutical Co Ltd
SHG:603590 |
$686.41 Million | CN¥4.69 Billion | China | CN¥29.50 | -5.54% | -10.14% | 117.47 Million |
| 330 |
Basilea Pharmaceutica AG
SW:BSLN |
$686.09 Million | CHF542.68 Million | Switzerland | CHF52.20 | -0.38% | -0.19% | 598.31K |
| 331 |
Aura Biosciences Inc
NASDAQ:AURA |
$683.95 Million | $683.95 Million | USA | $7.11 | +1.43% | +1.43% | 14.19 Million |
| 332 |
BridgeBio Oncology Therapeutics, Inc.
NASDAQ:BBOT |
$680.91 Million | $680.91 Million | USA | $8.50 | +3.22% | -4.49% | 8.91 Million |
| 333 |
Neurogene Inc
NASDAQ:NGNE |
$670.33 Million | $670.33 Million | USA | $33.60 | -0.18% | -6.95% | 7.21 Million |
| 334 |
BIOCYTOGEN PHARMA. H YC1
F:I54 |
$665.23 Million | €569.01 Million | Germany | €5.30 | -4.50% | -7.02% | 300.00 |
| 335 |
Shenzhen Weiguang Biological Products Co Ltd
SHE:002880 |
$655.46 Million | CN¥4.48 Billion | China | CN¥19.75 | +0.36% | -0.15% | 44.16 Million |
| 336 |
Sunmax Biotechnology Co Ltd
TWO:4728 |
$653.75 Million | NT$20.75 Billion | Taiwan | NT$381.00 | +0.79% | +0.26% | 133.73K |
| 337 |
ABBISKO CAYMAN DL-00001
F:8ZD |
$653.62 Million | €559.08 Million | Germany | €1.07 | -7.76% | -8.55% | 0.00 |
| 338 |
Oculis Holding AG Ordinary shares
NASDAQ:OCS |
$650.01 Million | $650.01 Million | USA | $11.21 | +3.41% | -1.92% | 8.90 Million |
| 339 |
DNA Link Inc
KQ:127120 |
$648.77 Million | ₩957.33 Billion | Korea | ₩27750.00 | -7.35% | -15.78% | 3.04 Million |
| 340 |
R&G PharmaStudies Co. Ltd. A
SHE:301333 |
$645.45 Million | CN¥4.41 Billion | China | CN¥45.67 | -5.52% | -9.83% | 99.99 Million |
| 341 |
Sinovac Biotech Ltd
NASDAQ:SVA |
$642.44 Million | $642.44 Million | USA | $6.47 | +0.00% | +0.00% | 0.00 |
| 342 |
Achieve Life Sciences Inc
NASDAQ:ACHV |
$639.57 Million | $639.57 Million | USA | $6.30 | +2.02% | -0.16% | 48.25 Million |
| 343 |
EirGenix
TWO:6589 |
$632.48 Million | NT$20.08 Billion | Taiwan | NT$66.40 | +0.00% | +0.00% | 579.36K |
| 344 |
MiMedx Group Inc
NASDAQ:MDXG |
$632.40 Million | $632.40 Million | USA | $4.27 | +0.95% | +2.40% | 34.66 Million |
| 345 |
ChemPartner PharmaTech Co Ltd
SHE:300149 |
$626.66 Million | CN¥4.28 Billion | China | CN¥8.60 | -3.80% | -12.96% | 1.19 Billion |
| 346 |
Climb Bio Inc
NASDAQ:CLYM |
$624.74 Million | $624.74 Million | USA | $12.08 | -0.25% | -3.97% | 34.50 Million |
| 347 |
Anhui Huaheng Biotechnology Co. Ltd. A
SHG:688639 |
$623.29 Million | CN¥4.26 Billion | China | CN¥17.03 | +2.16% | +6.57% | 185.94 Million |
| 348 |
Oneness Biotech Co Ltd
TWO:4743 |
$620.25 Million | NT$19.69 Billion | Taiwan | NT$41.15 | -2.60% | -13.73% | 91.36 Million |
| 349 |
Xiangxue Pharmaceutical
SHE:300147 |
$617.37 Million | CN¥4.22 Billion | China | CN¥6.38 | +1.92% | -3.04% | 318.18 Million |
| 350 |
Alpha Tau Medical Ltd
NASDAQ:DRTS |
$614.75 Million | $614.75 Million | USA | $11.89 | +6.35% | -8.61% | 19.32 Million |
| 351 |
SHANGHAI JUNSHI BIO YC1
F:8SJ |
$614.71 Million | €525.80 Million | Germany | €2.02 | -1.94% | -4.72% | 0.00 |
| 352 |
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued
NASDAQ:TRAXV |
$613.49 Million | $613.49 Million | USA | $17.66 | +3.55% | -3.37% | 11.17 Million |
| 353 |
Bright Minds Biosciences Inc
NASDAQ:DRUG |
$604.13 Million | $604.13 Million | USA | $74.63 | +5.02% | -1.10% | 6.38 Million |
| 354 |
Wuhan Hvsen Biotechnology Co Ltd
SHE:300871 |
$602.95 Million | CN¥4.12 Billion | China | CN¥20.42 | -0.63% | +0.54% | 197.99 Million |
| 355 |
Candel Therapeutics Inc
NASDAQ:CADL |
$597.89 Million | $597.89 Million | USA | $9.87 | +5.00% | -2.18% | 37.47 Million |
| 356 |
MapLight Therapeutics, Inc. Common Stock
NASDAQ:MPLT |
$597.82 Million | $597.82 Million | USA | $14.03 | -6.59% | -60.27% | 30.44 Million |
| 357 |
CorMedix Inc
NASDAQ:CRMD |
$587.53 Million | $587.53 Million | USA | $7.49 | +4.17% | -5.67% | 27.01 Million |
| 358 |
Regulus Therapeutics Inc
NASDAQ:RGLS |
$564.95 Million | $564.95 Million | USA | $8.16 | +0.00% | +0.00% | 9.34 Million |
| 359 |
Gyre Therapeutics Inc.
NASDAQ:GYRE |
$563.73 Million | $563.73 Million | USA | $5.81 | +3.01% | -2.19% | 2.38 Million |
| 360 |
Relmada Therapeutics Inc
NASDAQ:RLMD |
$561.16 Million | $561.16 Million | USA | $5.35 | +4.09% | +7.00% | 55.41 Million |
| 361 |
ARS Pharmaceuticals, Inc
NASDAQ:SPRY |
$559.06 Million | $559.06 Million | USA | $5.63 | -3.43% | -7.10% | 54.42 Million |
| 362 |
Beijing Bohui Innovation Technology Co Ltd
SHE:300318 |
$553.46 Million | CN¥3.78 Billion | China | CN¥4.63 | -1.07% | +1.09% | 259.98 Million |
| 363 |
Clarity Pharmaceuticals Ltd
AU:CU6 |
$553.13 Million | AU$781.74 Million | Australia | AU$2.10 | +0.48% | -10.26% | 69.27 Million |
| 364 |
Wecome Pharmaceutical Co Ltd
SHE:300878 |
$547.27 Million | CN¥3.74 Billion | China | CN¥25.83 | -4.08% | -4.93% | 136.48 Million |
| 365 |
Prime Medicine, Inc. Common Stock
NASDAQ:PRME |
$545.46 Million | $545.46 Million | USA | $3.02 | -0.33% | -2.27% | 96.97 Million |
| 366 |
Sage Therapeutics Inc
NASDAQ:SAGE |
$544.94 Million | $544.94 Million | USA | $8.68 | +0.00% | +0.00% | 0.00 |
| 367 |
Hefei Lifeon Pharmaceutical Co Ltd
SHE:003020 |
$539.67 Million | CN¥3.69 Billion | China | CN¥16.16 | -2.83% | -1.16% | 385.01 Million |
| 368 |
Tectonic Therapeutic, Inc.
NASDAQ:TECX |
$537.96 Million | $537.96 Million | USA | $28.51 | +0.28% | -9.75% | 5.02 Million |
| 369 |
Arvinas Inc
NASDAQ:ARVN |
$535.50 Million | $535.50 Million | USA | $8.30 | +0.97% | +0.48% | 16.60 Million |
| 370 |
Beijing Scitop Bio Tech Co Ltd
SHE:300858 |
$527.08 Million | CN¥3.60 Billion | China | CN¥13.67 | -1.44% | +0.89% | 116.01 Million |
| 371 |
Regenxbio Inc
NASDAQ:RGNX |
$523.18 Million | $523.18 Million | USA | $10.12 | +5.20% | -0.78% | 56.18 Million |
| 372 |
Eikon Therapeutics, Inc. Common Stock
NASDAQ:EIKN |
$520.81 Million | $520.81 Million | USA | $9.62 | +6.77% | +0.10% | 10.69 Million |
| 373 |
Pulike Biological Engineering
SHG:603566 |
$520.58 Million | CN¥3.56 Billion | China | CN¥10.28 | +0.59% | +0.98% | 73.91 Million |
| 374 |
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
$519.76 Million | CN¥3.55 Billion | China | CN¥3.45 | -3.63% | -0.58% | 1.56 Billion |
| 375 |
Zevra Therapeutics Inc.
NASDAQ:ZVRA |
$516.25 Million | $516.25 Million | USA | $9.64 | -1.43% | -20.59% | 38.81 Million |
| 376 |
4D Molecular Therapeutics Inc
NASDAQ:FDMT |
$514.09 Million | $514.09 Million | USA | $10.07 | +4.79% | -8.12% | 20.85 Million |
| 377 |
OPTHEA LTD (SP.ADR/8)
F:UKJ2 |
$512.99 Million | €438.79 Million | Germany | €3.00 | +0.00% | +0.00% | 0.00 |
| 378 |
Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ:CTNM |
$510.32 Million | $510.32 Million | USA | $15.75 | +9.53% | +6.92% | 10.45 Million |
| 379 |
Assure Tech Hangzhou Co Ltd
SHG:688075 |
$509.54 Million | CN¥3.48 Billion | China | CN¥27.40 | -1.33% | +0.18% | 18.84 Million |
| 380 |
Guangzhou Boji Medical and Biotechnological Co Ltd
SHE:300404 |
$506.33 Million | CN¥3.46 Billion | China | CN¥8.97 | -5.28% | -7.53% | 546.75 Million |
| 381 |
CHA Biotech Co. Ltd
KQ:085660 |
$505.92 Million | ₩746.55 Billion | Korea | ₩8030.00 | -0.86% | -6.08% | 7.20 Million |
| 382 |
AgomAb Therapeutics NV American Depositary Shares
NASDAQ:AGMB |
$488.54 Million | $488.54 Million | USA | $12.76 | +2.86% | +9.96% | 2.14 Million |
| 383 |
Lifecome Biochemistry Co Ltd
SHE:002868 |
$485.09 Million | CN¥3.32 Billion | China | CN¥21.33 | -3.92% | -0.79% | 58.84 Million |
| 384 |
Shanghai Shen Lian Biomedical Corp
SHG:688098 |
$483.73 Million | CN¥3.31 Billion | China | CN¥8.05 | -2.31% | -2.66% | 112.93 Million |
| 385 |
Rigel Pharmaceuticals Inc
NASDAQ:RIGL |
$481.79 Million | $481.79 Million | USA | $38.06 | -2.59% | +0.69% | 8.96 Million |
| 386 |
Achieve Life Sciences Inc
F:SP4P |
$480.44 Million | €410.95 Million | Germany | €5.30 | -0.93% | -5.36% | 566.00 |
| 387 |
TaiMed Biologics
TWO:4147 |
$479.31 Million | NT$15.21 Billion | Taiwan | NT$56.20 | -0.53% | -3.77% | 44.15 Million |
| 388 |
Medigen Vaccine Biologics
TWO:6547 |
$472.30 Million | NT$14.99 Billion | Taiwan | NT$45.60 | -0.22% | -4.10% | 54.10 Million |
| 389 |
Immix Biopharma Inc
NASDAQ:IMMX |
$465.22 Million | $465.22 Million | USA | $8.55 | +4.65% | -9.14% | 50.04 Million |
| 390 |
Hinova Pharmaceuticals Inc. A
SHG:688302 |
$463.36 Million | CN¥3.17 Billion | China | CN¥31.98 | -4.88% | -13.22% | 53.74 Million |
| 391 |
PharmaResources (Shanghai) Co. Ltd. A
SHE:301230 |
$460.60 Million | CN¥3.15 Billion | China | CN¥22.55 | -6.47% | -14.91% | 341.97 Million |
| 392 |
I-Mab
NASDAQ:IMAB |
$456.45 Million | $456.45 Million | USA | $3.96 | -1.74% | +0.25% | 11.39 Million |
| 393 |
Kyverna Therapeutics, Inc. Common Stock
NASDAQ:KYTX |
$455.36 Million | $455.36 Million | USA | $7.49 | +5.94% | +1.22% | 33.31 Million |
| 394 |
Prothena Corporation plc
NASDAQ:PRTA |
$452.71 Million | $452.71 Million | USA | $8.41 | -1.75% | -0.36% | 14.31 Million |
| 395 |
Iteos Therapeutics Inc
NASDAQ:ITOS |
$448.68 Million | $448.68 Million | USA | $10.15 | +0.00% | -0.49% | 32.79 Million |
| 396 |
Sagimet Biosciences Inc. Series A Common Stock
NASDAQ:SGMT |
$447.26 Million | $447.26 Million | USA | $7.31 | +3.84% | +3.69% | 29.57 Million |
| 397 |
Assembly Biosciences Inc
NASDAQ:ASMB |
$446.98 Million | $446.98 Million | USA | $26.06 | +3.78% | +0.08% | 5.33 Million |
| 398 |
Replimune Group Inc
NASDAQ:REPL |
$446.72 Million | $446.72 Million | USA | $5.41 | +0.00% | -49.67% | 114.38 Million |
| 399 |
Verastem Inc
NASDAQ:VSTM |
$446.40 Million | $446.40 Million | USA | $6.10 | +1.50% | +3.57% | 67.63 Million |
| 400 |
Cabaletta Bio Inc
NASDAQ:CABA |
$443.51 Million | $443.51 Million | USA | $2.72 | +3.82% | -1.09% | 120.36 Million |
| 401 |
Baolingbao Biology Co Ltd
SHE:002286 |
$440.50 Million | CN¥3.01 Billion | China | CN¥7.91 | -2.94% | +8.80% | 173.12 Million |
| 402 |
VALNEVA SE SP.ADS/2
F:AYJ0 |
$438.08 Million | €374.72 Million | Germany | €4.32 | -0.92% | +0.93% | 0.00 |
| 403 |
Valneva SE
PA:VLA |
$433.53 Million | €370.82 Million | France | €2.17 | -1.81% | +1.07% | 9.71 Million |
| 404 |
Ginkgo Bioworks Holdings
NYSE:DNA |
$431.69 Million | $431.69 Million | USA | $8.09 | +6.17% | +3.32% | 22.86 Million |
| 405 |
Design Therapeutics Inc
NASDAQ:DSGN |
$430.65 Million | $430.65 Million | USA | $12.62 | +4.99% | +7.13% | 19.83 Million |
| 406 |
Genfit S.A.
PA:GNFT |
$424.82 Million | €363.37 Million | France | €14.00 | +3.09% | +5.90% | 10.21 Million |
| 407 |
Zhejiang Shouxiangu Pharm Co
SHG:603896 |
$423.25 Million | CN¥2.89 Billion | China | CN¥14.59 | -0.27% | +0.41% | 65.77 Million |
| 408 |
Benitec Biopharma Ltd ADR
NASDAQ:BNTC |
$420.65 Million | $420.65 Million | USA | $12.70 | -2.01% | -6.62% | 3.18 Million |
| 409 |
PureTech Health PLC
NASDAQ:PRTC |
$417.22 Million | $417.22 Million | USA | $17.38 | +4.51% | +4.95% | 97.99K |
| 410 |
Ocugen Inc
NASDAQ:OCGN |
$413.00 Million | $413.00 Million | USA | $1.26 | +5.88% | -2.33% | 187.46 Million |
| 411 |
Qingdao Vland Biotech Co Ltd
SHG:603739 |
$411.73 Million | CN¥2.81 Billion | China | CN¥11.12 | -0.63% | +1.18% | 80.94 Million |
| 412 |
Ovid Therapeutics Inc
NASDAQ:OVID |
$410.10 Million | $410.10 Million | USA | $2.37 | +3.49% | -0.42% | 61.14 Million |
| 413 |
Evommune, Inc.
NYSE:EVMN |
$408.81 Million | $408.81 Million | USA | $11.35 | +2.71% | -0.44% | 30.01 Million |
| 414 |
Guanhao Biotech Co Ltd
SHE:300238 |
$407.41 Million | CN¥2.78 Billion | China | CN¥10.50 | -3.76% | -0.66% | 180.11 Million |
| 415 |
Autolus Therapeutics Ltd
NASDAQ:AUTL |
$407.20 Million | $407.20 Million | USA | $1.53 | +4.79% | +6.25% | 26.63 Million |
| 416 |
C4 Therapeutics Inc
NASDAQ:CCCC |
$404.68 Million | $404.68 Million | USA | $3.66 | +3.98% | -2.14% | 95.44 Million |
| 417 |
Guangdong VTR Bio-Tech Co Ltd
SHE:300381 |
$404.56 Million | CN¥2.76 Billion | China | CN¥5.63 | -0.18% | +3.68% | 203.61 Million |
| 418 |
Allogene Therapeutics Inc
NASDAQ:ALLO |
$404.51 Million | $404.51 Million | USA | $1.97 | +8.84% | +5.91% | 226.83 Million |
| 419 |
Zota Health Care LImited
NSE:ZOTA |
$401.98 Million | Rs37.17 Billion | India | Rs1225.40 | -1.38% | -4.07% | 1.36 Million |
| 420 |
Apellis Pharmaceuticals Inc
NASDAQ:APLS |
$400.77 Million | $400.77 Million | USA | $3.13 | +2.62% | -1.79% | 3.04K |
| 421 |
Monopar Therapeutics Inc
NASDAQ:MNPR |
$395.88 Million | $395.88 Million | USA | $114.66 | +6.73% | +1.94% | 6.18 Million |
| 422 |
Century Therapeutics Inc
NASDAQ:IPSC |
$394.98 Million | $394.98 Million | USA | $2.19 | +8.42% | +1.86% | 45.04 Million |
| 423 |
Y mAbs Therapeutics
NASDAQ:YMAB |
$391.22 Million | $391.22 Million | USA | $8.61 | +0.23% | +0.35% | 21.23 Million |
| 424 |
Beijing Kawin Technology Share-holding Co Ltd
SHG:688687 |
$387.73 Million | CN¥2.65 Billion | China | CN¥15.50 | -1.71% | -1.40% | 94.31 Million |
| 425 |
ASYMCHEM LAB.(TIAN.)H YC1
F:7K90 |
$383.99 Million | €328.45 Million | Germany | €11.80 | -6.35% | -11.94% | 0.00 |
| 426 |
Puma Biotechnology Inc
NASDAQ:PBYI |
$382.08 Million | $382.08 Million | USA | $7.89 | +1.02% | +0.25% | 8.87 Million |
| 427 |
SHANDONG BOAN BIOTECH.H 1
F:UJ9 |
$381.98 Million | €326.73 Million | Germany | €0.53 | -1.87% | -4.55% | 0.00 |
| 428 |
Eupraxia Pharmaceuticals Inc. Common Stock
NASDAQ:EPRX |
$381.57 Million | $381.57 Million | USA | $6.55 | +9.72% | +2.02% | 9.07 Million |
| 429 |
Enanta Pharmaceuticals Inc
NASDAQ:ENTA |
$378.02 Million | $378.02 Million | USA | $13.00 | +4.42% | -0.46% | 5.13 Million |
| 430 |
X4 Pharmaceuticals Inc
NASDAQ:XFOR |
$377.28 Million | $377.28 Million | USA | $4.00 | +0.00% | +8.25% | 25.41 Million |
| 431 |
Vigil Neuroscience Inc
NASDAQ:VIGL |
$375.71 Million | $375.71 Million | USA | $8.05 | +0.00% | +0.00% | 8.00 Million |
| 432 |
Qurient Co. Ltd
KQ:115180 |
$375.00 Million | ₩553.36 Billion | Korea | ₩14850.00 | -1.92% | -9.95% | 2.73 Million |
| 433 |
Larimar Therapeutics Inc
NASDAQ:LRMR |
$373.98 Million | $373.98 Million | USA | $3.83 | +5.37% | -4.85% | 63.40 Million |
| 434 |
Altimmune Inc
NASDAQ:ALT |
$373.19 Million | $373.19 Million | USA | $2.98 | +2.05% | +6.05% | 114.68 Million |
| 435 |
Yantai Zhenghai Bio-Tech Co Ltd
SHE:300653 |
$368.76 Million | CN¥2.52 Billion | China | CN¥14.00 | -0.64% | +1.01% | 53.92 Million |
| 436 |
Hansa Biopharma AB
ST:HNSA |
$368.11 Million | Skr3.42 Billion | Sweden | Skr34.30 | -5.56% | +6.92% | 15.61 Million |
| 437 |
Checkpoint Therapeutics Inc
NASDAQ:CKPT |
$367.72 Million | $367.72 Million | USA | $4.26 | +0.00% | +0.00% | 8.67 Million |
| 438 |
Autolus Therapeutics plc
F:6A3A |
$361.95 Million | €309.60 Million | Germany | €1.32 | +5.60% | +4.76% | 260.00 |
| 439 |
Shanghai Model Organisms Center Inc
SHG:688265 |
$361.19 Million | CN¥2.47 Billion | China | CN¥31.66 | -2.01% | -7.21% | 35.44 Million |
| 440 |
Shenzhen Bioeasy Biotechnology Co. Ltd.
SHE:300942 |
$359.80 Million | CN¥2.46 Billion | China | CN¥6.07 | +0.17% | +6.30% | 231.89 Million |
| 441 |
Nanhua Bio Medicine Co Ltd
SHE:000504 |
$356.88 Million | CN¥2.44 Billion | China | CN¥7.39 | -3.02% | -5.74% | 233.11 Million |
| 442 |
Pharmicell
KO:005690 |
$356.22 Million | ₩525.64 Billion | Korea | ₩8760.00 | -2.45% | -18.28% | 15.06 Million |
| 443 |
Upstream Bio, Inc.
NASDAQ:UPB |
$355.03 Million | $355.03 Million | USA | $6.57 | +2.50% | -0.30% | 12.35 Million |
| 444 |
Aclaris Therapeutics Inc
NASDAQ:ACRS |
$353.21 Million | $353.21 Million | USA | $5.32 | +3.91% | -5.34% | 51.15 Million |
| 445 |
Atea Pharmaceuticals Inc
NASDAQ:AVIR |
$351.32 Million | $351.32 Million | USA | $4.74 | +2.60% | -1.46% | 9.90 Million |
| 446 |
Rocket Pharmaceuticals Inc
NASDAQ:RCKT |
$350.51 Million | $350.51 Million | USA | $3.21 | +2.23% | -2.73% | 50.35 Million |
| 447 |
Compass Therapeutics Inc.
NASDAQ:CMPX |
$349.37 Million | $349.37 Million | USA | $1.94 | +0.00% | -4.90% | 64.27 Million |
| 448 |
Hyundai Bioscience Co. Ltd
KQ:048410 |
$342.99 Million | ₩506.12 Billion | Korea | ₩5270.00 | -2.23% | -11.73% | 20.14 Million |
| 449 |
DiaMedica Therapeutics Inc
NASDAQ:DMAC |
$340.54 Million | $340.54 Million | USA | $6.51 | +3.01% | -6.13% | 6.14 Million |
| 450 |
Palisade Bio Inc
NASDAQ:PALI |
$340.22 Million | $340.22 Million | USA | $1.96 | +0.00% | +3.16% | 102.50 Million |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries